Lipoxin A4 inhibits NF-κB activation and cell cycle progression in RAW264.7 cells

Inflammation

Volumn 37, Issue 4, 2014, Pages 1084-1090

  Huang, Yong Hong ^a   Wang, Hong Mei ^a   Cai, Zhen Yu ^a   Xu, Fang Yun ^a   Zhou, Xiao Yan ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

cell cycle; eicosanoids; inflammation; lipopolysaccharide; macrophages

Indexed keywords

ANTIMITOTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CYCLIN E; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOXIN A; LIPOXIN A 4; UNCLASSIFIED DRUG; I KAPPA B; LIPOPOLYSACCHARIDE; LIPOXIN;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; FLOW CYTOMETRY; IN VITRO STUDY; INTRACELLULAR SIGNALING; MACROPHAGE; MITOSIS INHIBITION; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; CELL CYCLE; CELL LINE; CHEMISTRY; CYTOLOGY; INFLAMMATION; METABOLISM; MOUSE; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CYCLIN E; DOWN-REGULATION; FLOW CYTOMETRY; I-KAPPA B PROTEINS; INFLAMMATION; LIPOPOLYSACCHARIDES; LIPOXINS; MACROPHAGES; MICE; NF-KAPPA B; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 84904756707     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9832-2     Document Type: Article

References (44)

1. 4 and its receptor in upper airway inflammation. Annals of Otology, Rhinology and Laryngology 122(11): 683-689.
2. 4 increases survival by decreasing systemic inflammation and bacterial load in sepsis. Shock 36(4): 410-416.
3. 4 protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brain. PLoS One 8(4): e618882.
4. 4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nature Medicine 12: 330-334.
5. 4 predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical test. FASEB Journal 27: 3938-3946.
6. 4 operative in murine microcirculation. Blood 25(122): 608-617.
7. 4 analog attenuates lipopolysaccharide- induced acute lung injury in mice: the role of heme oxygenase-1. Anesthesia and Analgesia 104: 369-377.
8. Jia, Y., E.F. Morand, W. Song, et al. 2013. Regulation of lung fibroblast activation by annexin A1. Journal of Cellular Physiology 228: 476-484.
9. Gavins, F.N., A.M. Kamal, M. D'Amico, et al. 2005. Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct. FASEB Journal 19: 100-102. (Pubitemid 40069931)
10. Zhou, X.Y., Z.J. Yu, D. Yan, et al. 2013. BML-111, a lipoxin receptor agonist, protected carbon tetrachloride-induced hepatic fibrosis in rats. Inflammation 36: 1101-1106.
11. Barnig, C., and B.D. Levy. 2013. Lipoxin A4: a new direction in asthma therapy? Expert Review of Clinical Immunology 9: 491-493.
12. Mangino, M.J., L. Brounts, B. Harms, et al. 2006. Lipoxin biosynthesis in inflammatory bowel disease. Prostaglandins & Other Lipid Mediators 79: 84-92.
13. Conte, F.P., O. Menezes-de-Lima Jr., Verri Jr. G., et al. 2010. Lipoxin A(4) attenuates zymosan-induced arthritis bymodulating endothelin-1 and its effects. British Journal of Pharmacology 161: 911-924.
14. 4 stimulates calcium-activated chloride currents and increases airway surface liquid height in normal and cystic fibrosis airway epithelia. PLoS One 7: e37746.
15. 4 levels in asthma: relation with disease severity and aspirin sensitivity. Clinical and Experimental Allergy 37: 1494-1501.
16. 4 and its receptor in synovitis of patients with rheumatoid arthritis. Journal of Rheumatology 34: 2144-2153.
17. Vallejo, A.N., C.M. Weyand, and J.J. Goronzy. 2004. T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends in Molecular Medicine 10: 119-124. (Pubitemid 38293347)
18. Pappas, K., A.I. Papaioannou, K. Kostikas, et al. 2013. The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma. Cytokine 64: 613-625.
19. Dalli, J., and C.N. Serhan. 2012. Specific lipid mediator signatures of human phagocytes:microparticles stimulatemacrophage efferocytosis and pro-resolving mediators. Blood 120: e60-e72.
20. 4 in children with acute poststreptococcal glomerulonephritis. American Journal of Pathology 174: 115-122.
21. 4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritis. Kidney International 47: 1295-1302.
22. 4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor. Proceedings of the National Academy of Sciences of the United States of America 86: 3438-3442.
23. Machado, F.S., and J. Aliberti. 2008. Role of lipoxin in the modulation of immune response during infection. International Immunopharmacology 8(10): 1316-1319.
24. Aliberti, J., S. Hieny, E.S.C. Reis, et al. 2002. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nature Immunology 3(1): 76-82. (Pubitemid 34065621)
25. 4 modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism. European Journal of Immunology. doi:10.1002/eji.201343316.
26. Claria, J., M.H. Lee, and C.N. Serhan. 1996. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Molecular Medicine 2(5): 583-596. (Pubitemid 26353107)
27. Chen, C., Y. Shen, Q.X. Qu, et al. 2013. Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response. Experimental Cell Research 319: 96-102.
28. Schoenhaut, D.S., A.O. Chua, A.G.Wolitzky, et al. 1992. Cloning and expression of murine IL-12. Journal of Immunology 148: 3433-3440.
29. Riccardi, C., R. Rossi, A. Giampietri, et al. 1984. Effects of interleukin-1 (IL-1) and interleukin-2 (IL-2) on the in vivo growth and differentiation of progenitors of natural killer (NK) cells. Chemioterapiav 3: 350-353. (Pubitemid 15165649)
30. Schwab, J.M., N. Chiang, M. Arita, et al. 2007. Resolvin E1 and Protectin D1 activate inflammation-resolution programs. Nature 447(7146): 869-874. (Pubitemid 46920139)
31. Chiang, N., G. Fredman, F. Backhed, et al. 2012. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484(7395): 524-528.
32. Lee, H.N., and Y.J. Surh. 2013. Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis. Biochemical Pharmacology 86(6): 759-769.
33. Chen, H., B. Sun, S. Wang, et al. 2010. Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-kappaB. Journal of Cancer Research and Clinical Oncology 136: 897-903.
34. Widera, D., I.Mikenberg, A. Kaus, et al. 2006. Nuclear factor-kappaB controls the reaggregation of 3D neurosphere cultures in vitro. European Cells and Materials 11: 76-84.
35. Liao, Z., J. Dong, W.Wu, et al. 2012. Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway. Respiratory Research 13: 110.
36. Zhang, X., T.Wang, P. Gui, et al. 2013. Resolvin D1 reverts lipopolysaccharide-induced TJ proteins disruption and the increase of cellular permeability by regulating IκBα signaling in human vascular endothelial cells. Oxidative Medicine and Cellular Longevity 2013: 185715.
37. 4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B andAP-1 activation, and IL-8 gene expression in human leukocytes. Proceedings of the National Academy of Sciences of the United States of America 99: 13266-13271.
38. Schmitz, M.L., and P.A. Baeuerle. 1995. Multi-step activation of NF-κB/Rel transcription factors. Immunobiology 193: 116-127.
39. Kumar, A., Y. Takada, A.M. Boriek, et al. 2004. Nuclear factor-kappaB: its role in health and disease. Journal of Molecular Medicine 82: 434-848.
40. Fiore, S., J.F. Maddox, H.D. Perez, et al. 1994. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. Journal of Experimental Medicine 180: 253-260. (Pubitemid 24181074)
41. 4 stable analogs are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. Journal of Experimental Medicine 185: 1693-1704.
42. 4 receptor that is conserved in structure and function. British Journal of Pharmacology 139: 89-98.
43. Murphy, P.M., T. Ozcelik, R.T. Kenney, et al. 1992. A structural homologue of the N-formyl peptide receptor: characterization and chromosomal mapping of a peptide chemoattractant receptor gene family. Journal of Biology Chemistry 267: 7637-7643.
44. Ye, R.D., S.L. Cavanagh, O. Quehenberger, et al. 1992. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochemical and Biophysical Research Communications 184: 582-589.